MAY 15, 2018 8:10 PM PDT

Cancer Education Resources for Patients

WRITTEN BY: Mauri Brueggeman

Have you ever met patients or people who did not have a medical background? Have you heard them tell you that medicine is so hard to understand and when given a complex diagnosis like cancer, understanding what is happening seems like a whirlwind?  This test and that test…X treatment versus Y treatment…some kind of something therapy…markers mean what exactly…etc.? 

A cancer diagnosis is complex.  Even the term “cancer” has connections to other diagnostic words that can mean cancer but sound very different including neoplasia, malignancy, tumor, neoplasm, and oncogenes.  Educators and those in the medical field know this language but it is still very foreign to so many. 

The National Comprehensive Cancer Network (NCCN®) has developed patient education tools in an effort to provide basic information about individual cancers including etiology (how and where it develops), diagnosis, tests, marker details, treatment planning, treatment options, differing prognostic indicators, supportive care ideas, helpful questions to ask, things to possibly expect, helpful website links, and a list of acronyms near the end of the booklet.  There are diagrams and pictures to help in patients’ understanding.    NCCN® collaborates with other organizations to garner support for their tools and lists those collaborators in these booklets as well.

The provider and oncology staff help patients immensely with their questions and to help navigate the process and experience; however, having tools like this in the hands of patients, developed almost like a learning workbook with spaces for notes and individualization, make these an excellent tool for patients to have on hand when they aren’t with people who can define this test or that. 

The goal of these tools is to help patient’s in the shared decision-making process and to make informed decisions.  Because many of these cancer diagnoses are so complex based on numerous factors, patients don’t even realize one individual’s Acute Myeloid Leukemia (AML) diagnosis can look very different and need different treatment than the next person’s.  Some are published in a variety of languages to meet the needs of diverse patient populations.

These booklets are updated with the oldest version not updated yet being Brain Cancer/Gliomas, published in 2016.  The current list of cancer guides includes booklets (ranging in page number but approximately 50+ pages) on:

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Brain Cancer/Gliomas

Breast Cancer: Stage 0

Breast Cancer: Stage I & II

Breast Cancer: Stage III

Breast Cancer: Stage IV

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Colon Cancer

Diffuse Large B-Cell Lymphoma

Esophageal Cancer

Follicular Lymphoma

Hodgkin Lymphoma

Kidney Cancer

Lung Cancer

Lung Cancer Screening

Malignant Pleural Mesothelioma

Mantle Cell Lymphoma

Melanoma

Multiple Myeloma

Mycosis Fungoides

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Non-Hodgkin’s Lymphoma-Peripheral T-Cell Lymphoma

Ovarian Cancer

Pancreatic Cancer

Prostate Cancer

Rectal Cancer

Soft Tissue Carcinoma

Stomach Cancer

Thyroid Cancer

Waldenström’s Macroglobulinemia (Lymphoplasmacytic Lymphoma)

Distress Supportive Care after Cancer Diagnosis

Cancer Induced Nausea & Vomiting

Adolescents and Young Adults with Cancer

Source: National Comprehensive Cancer Network

 

About the Author
MEd
Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
DEC 03, 2021
Drug Discovery & Development
FDA approves new imaging drug to make ovarian cancer tumors glow.
DEC 03, 2021
FDA approves new imaging drug to make ovarian cancer tumors glow.
Earlier this week, the United States Food and Drug Administration (FDA) announced its approval for a novel dru ...
JAN 13, 2022
Cancer
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
JAN 13, 2022
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
The American Cancer Society estimates the lifetime risk of pancreatic cancer at about 1 in 64. Pancreatic duct ...
JAN 21, 2022
Cannabis Sciences
CBD inhalant effective in reducing glioblastoma tumors
JAN 21, 2022
CBD inhalant effective in reducing glioblastoma tumors
Researchers at Augusta University found that hat CBD inhalant can alter the lung microenvironment and subsequently inhib ...
FEB 08, 2022
Immunology
Biomaterial Makes Cancer Cells 10 Times More Sensitive
FEB 08, 2022
Biomaterial Makes Cancer Cells 10 Times More Sensitive
  Tumors have a sneaky strategy of becoming resistant to chemotherapy drugs—they have a way of “pumping ...
APR 20, 2022
Cancer
"Saturating" the Liver with Chemotherapy to Treat Cancer
APR 20, 2022
"Saturating" the Liver with Chemotherapy to Treat Cancer
Uveal melanoma is a rare type of cancer that grows in the melanin, the dark-colored pigment of the eye. About  ...
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
Loading Comments...